NPPA sets Ceiling Price for Gufic Meropenem Dual Chamber Bag

The National Pharmaceutical Pricing Authority (NPPA) has handed a special ceiling price for the product of Meropenem Powder for Injection in dual chamber bags by Gufic Biosciences Limited

Sun Pharma & Lupin to develop affordable anti-obesity pills

India's prominent drug manufacturers Sun Pharmaceutical Industries and Lupin Ltd are advancing toward making affordable anti-obesity pills as the country faces a rapidly growing obesity epidemic. According to a report, the Drugs Controller General...

Swiss AI Healthcare Firm Partners with Indian Startup for Diagnostics

In this modern age of Artificial Intelligence, it is important to provide the new age AI driven solutions to the society in the healthcare sector also. In a strategic move to strengthen healthcare innovation in India

Eli Lilly Wins USFDA Breakthrough for Olomorasib in Lung Cancer Therapy

Eli Lilly and Company has been given the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for olomorasib combined with anti-PD-1 therapy Keytruda

Poly Medicure Acquires 90% Stake in PendraCare to Boost Cardiology

Poly Medicure, India's largest medical device company announced its acquisition of 90% of the PendraCare Group, including PendraCare Holdings and Wellinq Medical, from Wellinq Holdings B.V. The deal has an enterprise value of €18.3 million...

Sanofi Highlights 31 Abstracts on Inflammatory Respiratory Diseases at ERS

Sanofi's approved and pipeline medications aimed at addressing significant care gaps in chronic inflammatory respiratory diseases will be showcased at the European Respiratory Society (ERS) International Congress.

Glenmark Initiates Global Phase 3 Trial for Novel Lung Cancer Drug

Glenmark Pharmaceuticals has also begun a global Phase 3 clinical trial with Envafolimab, a new medication to treat patients with third stage non-small cell lung cancer (NSCLC). The shift highlights the increasing role of India in late-stage drug dev

Pfizer Partners DPIIT to Strengthen India's Healthcare Innovation Drive

The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has partnered with Pfizer Limited by signing a Memorandum of Understanding

Edwards Lifesciences Launches Next-Gen Transcatheter Heart Valve in India

Edwards Lifesciences has launched its new-gen transcatheter heart valve platform in India, marking a significant advance in the treatment of severe aortic stenosis. The system is intended for patients that are not suitable candidates for open-hear...

Govt Removes GST on 33 Critical Life-Saving Medicines

The GST Council has removed the 12% Goods and Services Tax (GST) on 33 high-cost life-saving drugs and diagnostic kits, resulting in these items being tax-free and thus relieving the burden on patients.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.